demonstrated curcumin's ability to enhance the therapeutic index of cytarabine while suppressing MDR gene expression, including MDR1, LRP, and BCRP, in both wild‐type FLT3 and FLT3‐ITD AML models (Ahmed et al. 2020). This evidence concerns the gene FLT3 and acute myeloid leukemia.